SCHEDULE 13G/A

Protara Therapeutics Inc

Common Stock, $0.001 par value per share (the "Shares") · CUSIP: 74365U107

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Citadel Advisors LLC

  Shares: 1,612,531.00 · Class: 4.6%

• Citadel Advisors Holdings LP

  Shares: 1,612,531.00 · Class: 4.6%

• Citadel GP LLC

  Shares: 1,612,531.00 · Class: 4.6%

• Citadel Securities LLC

  Shares: 15,203.00 · Class: 0.0%

• Citadel Securities Group LP

  Shares: 15,203.00 · Class: 0.0%

• Citadel Securities GP LLC

  Shares: 15,203.00 · Class: 0.0%

• Kenneth Griffin

  Shares: 1,627,734.00 · Class: 4.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.